First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Thermo Fisher Scientific Inc.

    TMO · 5 developments mapped · last assessed 2026-09-29

    Market Ontology has mapped 5 macro, policy, and market developments to Thermo Fisher Scientific Inc. since 2026-08-20. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for TMO yet, so no modelled value is shown. The TMO valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run TMO on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for TMO. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Strongest support

      Automated AI Microscopy Sector Projected to Reach $16.63B by 2035 at 7.35% CAGR

      Increased demand for life science digital pathology and research instrumentation, where TMO is a leading provider of microscopy and analytical instruments.

      · Moves long term revenue growth rate, market share in key segments

    • Open question

      Merck KGaA to acquire Bio-Techne Corporation for $73.00 per share in cash

      Potential re-evaluation of sector valuations and competitive landscape.

      · Moves sector m&a premium, competitive positioning in life sciences tools

    What changed, by assumption

    Long term revenue growth rate
    • 2026-09-23Automated AI Microscopy Sector Projected to Reach $16.63B by 2035 at 7.35% CAGR
    Revenue growth rate
    • 2026-09-21Magnetic Bead Purification Market Forecast to Expand at 10.5% CAGR to $6.73B by 2030
    Sector m&a premium
    • 2026-08-20Merck KGaA to acquire Bio-Techne Corporation for $73.00 per share in cash
    Market share in proteomics
    • 2026-09-29Quantum-Si Interim Proteus Data Shows 30x Alignment Gain Over Platinum Pro
    Growth in demand for laboratory equipment and services
    • 2026-09-22Bureau Veritas Raises 2027-2028 Revenue Growth Guidance to Double Digits

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-29Quantum-Si Interim Proteus Data Shows 30x Alignment Gain Over Platinum Prowatch3-12m0.20
    2026-09-23Automated AI Microscopy Sector Projected to Reach $16.63B by 2035 at 7.35% CAGRBullish1-5y0.70
    2026-09-22Bureau Veritas Raises 2027-2028 Revenue Growth Guidance to Double DigitsBullish3-12m0.20
    2026-09-21Magnetic Bead Purification Market Forecast to Expand at 10.5% CAGR to $6.73B by 2030Bullish1-5y0.70
    2026-08-20Merck KGaA to acquire Bio-Techne Corporation for $73.00 per share in cashmixed1-3m0.40